Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 32, Issue 3, Pages 577-582Publisher
WILEY
DOI: 10.1111/jgh.13611
Keywords
fecal markers; inflammation; inflammatory bowel disease
Categories
Ask authors/readers for more resources
Over the last two decades, knowledge on fecal biomarkers has substantially increased. Nowadays, these non-invasive markers of inflammation have significant clinical utility in the management of inflammatory bowel disease. Their use informs the decision to perform endoscopy before diagnosis is made right through to influencing therapeutic choices and the need for interval endoscopic assessment. In this review, the roles of two S100 proteins, calprotectin, and S100A12 are described along with that of lactoferrin, in the context of inflammatory bowel disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available